{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:56:15Z","timestamp":1776218175007,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015310","name":"Natural Science Foundation of Xinjiang","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009110","name":"Xinjiang Uygur Autonomous Region Natural Science Foundation","doi-asserted-by":"publisher","award":["2021D01C417"],"award-info":[{"award-number":["2021D01C417"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.heliyon.2023.e14132","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T20:58:51Z","timestamp":1677617931000},"page":"e14132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Role of hypoxia-inducible factor-1\u03b1 and survivin in breast cancer recurrence and prognosis"],"prefix":"10.1016","volume":"9","author":[{"given":"Qian","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munire","family":"Mushajiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-qiong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-qing","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e14132_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.07.002","article-title":"Breast cancer epidemiology, prevention, and screening","volume":"151","author":"Winters","year":"2017","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14132_bib2","first-page":"19","article-title":"Current strategies for the management of locoregional breast cancer recurrence","volume":"33","author":"Wapnir","year":"2019","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14132_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e14132_bib4","first-page":"297","article-title":"HIF-1\u03b1 promotes breast cancer cell MCF-7 proliferation and invasion through regulating miR-210","volume":"32","author":"Zhang","year":"2017","journal-title":"Cancer Biother. Radiopharm."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e14132_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01371","article-title":"Performance of survivin mRNA as a biomarker for breast cancer among Vietnamese women","volume":"5","author":"Nguyen","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2023.e14132_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fphar.2016.00081","article-title":"Inhibition of HDAC3- and HDAC6-promoted survivin expression plays an important role in SAHA-induced autophagy and viability reduction in breast cancer cells","volume":"7","author":"Lee","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14132_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14132_bib8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cell.2018.03.059","article-title":"SnapShot: TCGA-analyzed tumors","volume":"173","author":"Blum","year":"2018","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.heliyon.2023.e14132_bib9","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: an integrated repository portal for tumor-immune system interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e14132_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"issue":"151","key":"10.1016\/j.heliyon.2023.e14132_bib11","first-page":"29","article-title":"A direct immunohistochemistry (IHC) method improves the intraoperative diagnosis of breast papillary lesions including breast cancer","volume":"28","author":"Liu","year":"2019","journal-title":"Discov. Med."},{"key":"10.1016\/j.heliyon.2023.e14132_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-981-32-9705-0_9","article-title":"The role of early life stress in HPA Axis and anxiety","volume":"1191","author":"Juruena","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.heliyon.2023.e14132_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113967","article-title":"GO-based antibacterial composites: application and design strategies","volume":"178","author":"Hu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e14132_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2016.20324","article-title":"Trends and patterns of disparities in cancer mortality among US counties, 1980-2014","volume":"317","author":"Mokdad","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2023.e14132_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-030-20301-6_2","article-title":"Epidemiology of breast cancer in women","volume":"1152","author":"Coughlin","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"30","key":"10.1016\/j.heliyon.2023.e14132_bib16","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.2174\/1381612819666131125145517","article-title":"Breast cancer biomarkers: risk assessment, diagnosis, prognosis, prediction of treatment efficacy and toxicity, and recurrence","volume":"20","author":"Braden","year":"2014","journal-title":"Curr. Pharmaceut. Des."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e14132_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14132_bib18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12885-022-09371-0","article-title":"Pan-cancer analysis identifies BIRC5 as a prognostic biomarker","volume":"22","author":"F\u00e4ldt Beding","year":"2022","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e14132_bib19","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.3390\/ijms22041820","article-title":"The BIRC family genes expression in patients with triple negative breast cancer","volume":"22","author":"Makuch-Kocka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e14132_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/1471-2407-13-403","article-title":"Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype","volume":"13","author":"Wiese","year":"2013","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e14132_bib21","first-page":"1399","article-title":"Hypoxia-inducible factor-1\u03b1 expression and gemcitabine chemotherapy for pancreatic cancer","volume":"26","author":"Kasuya","year":"2011","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e14132_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0003489418765563","article-title":"Hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) expression on endothelial cells in juvenile nasopharyngeal angiofibroma: a review of 70 cases and tissue microarray analysis","volume":"127","author":"Song","year":"2018","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e14132_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4103\/0971-5916.159250","article-title":"Survivin: a molecular biomarker in cancer","volume":"141","author":"Jaiswal","year":"2015","journal-title":"Indian J. Med. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14132_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13058-021-01480-1","article-title":"Hypoxia-inducible factor-1\u03b1 expression and breast cancer recurrence in a Danish population-based case control study","volume":"23","author":"Collin","year":"2021","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14132_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/0284186X.2018.1503419","article-title":"Expression of survivin does not appear to influence breast cancer recurrence risk","volume":"58","author":"Collin","year":"2019","journal-title":"Acta Oncol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e14132_bib26","doi-asserted-by":"crossref","first-page":"815","DOI":"10.7150\/ijbs.20052","article-title":"FOXO signaling pathways as therapeutic targets in cancer","volume":"13","author":"Farhan","year":"2017","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14132_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13073-022-01093-z","article-title":"Single-cell genomic and transcriptomic landscapes of pri. y and metastatic colorectal cancer tumors","volume":"14","author":"Wang","year":"2022","journal-title":"Genome Med."},{"issue":"36","key":"10.1016\/j.heliyon.2023.e14132_bib28","doi-asserted-by":"crossref","first-page":"25903","DOI":"10.1074\/jbc.M603414200","article-title":"Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression","volume":"281","author":"Peng","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.heliyon.2023.e14132_bib29","doi-asserted-by":"crossref","first-page":"8251","DOI":"10.7314\/APJCP.2014.15.19.8251","article-title":"Upregulation of HIF-1\u03b1 by hypoxia protect neuroblastoma cells from apoptosis by promoting survivin expression","volume":"15","author":"Zhang","year":"2014","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"9935","key":"10.1016\/j.heliyon.2023.e14132_bib30","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"McGale","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2023.e14132_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cca.2013.10.018","article-title":"Hypoxia-inducible factor 1\u03b1 in breast cancer prognosis","volume":"428","author":"Wang","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e14132_bib32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/tbj.12303","article-title":"Prognostic significance of survivin in breast cancer: meta-analysis","volume":"20","author":"Li","year":"2014","journal-title":"Breast J."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023013397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023013397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:02:48Z","timestamp":1776214968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023013397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2405844023013397"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14132","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of hypoxia-inducible factor-1\u03b1 and survivin in breast cancer recurrence and prognosis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e14132"}}